
TOMI Environmental Solutions, Inc.
TOMZNASDAQIndustrialsIndustrial - Pollution & Treatment Controls
Regular session
$1.74
−$0.02 · -1.14%
TOMZ company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
39
Expensive
Momentum
42
Neutral
Sentiment
62
Bullish
Risk resilience
29
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteTOMI Environmental Solutions, Inc. is a company dedicated to controlling infectious diseases and decontaminating bacteria, offering sophisticated environmental solutions for sanitizing indoor surfaces globally and across the United States. Central to their operations is the development, sale, and licensing of SteraMist Binary Ionization Technology, which utilizes a hydrogen peroxide-based mist and fog for highly effective disinfection. Their diverse product lineup includes: The SteraMist Surface Unit, a portable, handheld device designed for quick, targeted disinfection of specific areas. The SteraMist Environment System, a transportable and remotely operated unit capable of completely disinfecting sealed rooms up to approximately 103.8 cubic meters. The SteraMist Hospital Disinfection Cart, specifically tailored for healthcare clients to elevate patient care and safety by decontaminating patient rooms, operating theaters, pharmacies, ambulances, and emergency zones within hospitals and other medical settings. Further offerings comprise the SteraMist Select Surface Unit, a Stainless Steel 90-Degree Applicator, the iHP Plasma Decontamination Chamber, and bespoke SteraMist Custom Engineered Systems. TOMI also provides iHP Corporate Service Decontamination, delivering comprehensive disinfection and decontamination services for entire rooms, equipment, facilities, and emergency situations. TOMI's advanced products and services are adopted across a broad spectrum of industries and settings. These range from hospitals, medical facilities, bio-safety labs, and pharmaceutical manufacturing plants to meat and produce processing facilities, universities, research institutions, and vivarium labs. Their solutions also extend to various service sectors like cruise ships, corporate offices, hotels, schools, restaurants, military barracks, police and fire departments, correctional facilities, and athletic venues, as well as residential properties including single-family homes and multi-unit dwellings. The company was established in 1979 and is based in Frederick, Maryland.
- Industry
- Industrial - Pollution & Treatment Controls
- Sector
- Industrials
- Headquarters
- US
- CEO
- Halden Stuart Shane
- Listed since
- Jun 20, 2008
- Employees
- 20
Market position
Day range
Current $1.74
52-week range
Current $1.74
- Open
- $1.9363
- Previous close
- $1.76
- Volume
- 7.99K
- 0.05× average
- Average volume
- 164.58K
- Average daily volume
- Market cap
- 13.4M USD
- Beta
- 1.98
- Market reference 1
- 50-day average
- $2.0234
- -14.01% below average
- 200-day average
- $2.1712
- -19.86% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 19.01M USD
- P/E (TTM)
- -3.37×
- P/B (TTM)
- 9.25×
- P/S (TTM)
- 1.93×
- EV / EBITDA
- -6.78×
- Earnings yield
- -23.93%
- Free cash flow yield
- -8.50%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 50.42%
- Operating margin
- -40.95%
- Net margin
- -49.77%
- Return on equity
- -637.04%
- Return on assets
- -53.30%
- Return on invested capital
- -96.00%
Financial health
- Debt / equity
- 2.38×
- Current ratio
- 1.32×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.64M USD | 7.74M USD | 7.35M USD | 8.34M USD | 7.75M USD |
| Cost of goods sold | 2.56M USD | 4.18M USD | 3.07M USD | 3.28M USD | 3.17M USD |
| Gross profit | 3.08M USD | 3.56M USD | 4.29M USD | 5.06M USD | 4.59M USD |
| Research and development | 289.9K USD | 290.68K USD | 491.8K USD | 352.24K USD | 572.7K USD |
| Selling, general, and administrative | 6.37M USD | 7.07M USD | 6.78M USD | 7.26M USD | 8.64M USD |
| Operating expenses | 6.93M USD | 7.66M USD | 7.64M USD | 7.94M USD | 9.51M USD |
| Interest income | 86.54K USD | 17.49K USD | 11.99K USD | 1.94K USD | 1.08K USD |
| Interest expense | 516.11K USD | 389.49K USD | 63.31K USD | — | 1.03K USD |
| Depreciation and amortization | 428.64K USD | 453.85K USD | 381.74K USD | 354.13K USD | 493.88K USD |
| Operating income | −3.85M USD | −4.1M USD | −3.35M USD | −2.88M USD | −4.92M USD |
| Net income | −3.75M USD | −4.48M USD | −3.4M USD | −2.88M USD | −4.44M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 36%
- 4 beats, 6 misses, 1 met estimate
- Average EPS surprise
- -138.61%
- 11 comparable reports
- Latest EPS result
- -0.05
- Estimate -0.11 · Beat by 54.55%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
TOMZ peers
ETFs holding TOMZ
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research TOMZresearch.disclaimer







